• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的血栓反应蛋白。

Thrombospondins in the tumor microenvironment.

机构信息

Department of Biomedical Sciences, University of Guelph, Guelph, ON, Canada.

Department of Biomedical Sciences, University of Guelph, Guelph, ON, Canada.

出版信息

Semin Cell Dev Biol. 2024 Mar 1;155(Pt B):3-11. doi: 10.1016/j.semcdb.2023.05.010. Epub 2023 Jun 5.

DOI:10.1016/j.semcdb.2023.05.010
PMID:37286406
Abstract

Many cancers begin with the formation of a small nest of transformed cells that can remain dormant for years. Thrombospondin-1 (TSP-1) initially promotes dormancy by suppressing angiogenesis, a key early step in tumor progression. Over time, increases in drivers of angiogenesis predominate, and vascular cells, immune cells, and fibroblasts are recruited to the tumor mass forming a complex tissue, designated the tumor microenvironment. Numerous factors, including growth factors, chemokine/cytokine, and extracellular matrix, participate in the desmoplastic response that in many ways mimics wound healing. Vascular and lymphatic endothelial cells, and cancer-associated pericytes, fibroblasts, macrophages and immune cells are recruited to the tumor microenvironment, where multiple members of the TSP gene family promote their proliferation, migration and invasion. The TSPs also affect the immune signature of tumor tissue and the phenotype of tumor-associated macrophages. Consistent with these observations, expression of some TSPs has been established to correlate with poor outcomes in specific types of cancer.

摘要

许多癌症始于一小群转化细胞的形成,这些细胞可以休眠多年。血小板反应蛋白-1(TSP-1)最初通过抑制血管生成来促进休眠,血管生成是肿瘤进展的关键早期步骤。随着时间的推移,血管生成的驱动因素增加,血管细胞、免疫细胞和成纤维细胞被招募到肿瘤块中,形成一个复杂的组织,称为肿瘤微环境。许多因素,包括生长因子、趋化因子/细胞因子和细胞外基质,参与了在许多方面模拟伤口愈合的促结缔组织反应。血管和淋巴管内皮细胞以及癌相关周细胞、成纤维细胞、巨噬细胞和免疫细胞被招募到肿瘤微环境中,TSP 基因家族的多个成员促进它们的增殖、迁移和侵袭。TSP 还影响肿瘤组织的免疫特征和肿瘤相关巨噬细胞的表型。与这些观察结果一致,某些 TSP 的表达已被确定与特定类型癌症的不良预后相关。

相似文献

1
Thrombospondins in the tumor microenvironment.肿瘤微环境中的血栓反应蛋白。
Semin Cell Dev Biol. 2024 Mar 1;155(Pt B):3-11. doi: 10.1016/j.semcdb.2023.05.010. Epub 2023 Jun 5.
2
Thrombospondin in Tumor Microenvironment.肿瘤微环境中的血栓反应蛋白
Adv Exp Med Biol. 2020;1272:133-147. doi: 10.1007/978-3-030-48457-6_8.
3
Thrombospondin-1 in drug activity and tumor response to therapies.血小板反应蛋白-1 在药物活性和肿瘤对治疗的反应中的作用。
Semin Cell Dev Biol. 2024 Mar 1;155(Pt B):45-51. doi: 10.1016/j.semcdb.2023.06.009. Epub 2023 Jul 4.
4
Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells.血小板反应蛋白 4/整合素α2/热休克因子 1 轴通过增强癌相关成纤维细胞和肿瘤细胞之间的相互串扰促进胆囊癌的增殖和癌症干细胞样特性。
J Exp Clin Cancer Res. 2021 Jan 6;40(1):14. doi: 10.1186/s13046-020-01812-7.
5
Thrombospondin-4 in tissue remodeling.组织重塑中的血栓反应蛋白-4。
Matrix Biol. 2019 Jan;75-76:300-313. doi: 10.1016/j.matbio.2017.11.006. Epub 2017 Nov 11.
6
Tumor progression: the effects of thrombospondin-1 and -2.肿瘤进展:血小板反应蛋白-1和-2的作用
Int J Biochem Cell Biol. 2004 Jun;36(6):1038-45. doi: 10.1016/j.biocel.2004.01.008.
7
Thrombospondin-based antiangiogenic therapy.基于血小板反应蛋白的抗血管生成疗法。
Microvasc Res. 2007 Sep-Nov;74(2-3):90-9. doi: 10.1016/j.mvr.2007.04.007. Epub 2007 May 6.
8
Pathophysiological roles of thrombospondin-4 in disease development.血栓反应蛋白-4在疾病发展中的病理生理学作用。
Semin Cell Dev Biol. 2024 Mar 1;155(Pt B):66-73. doi: 10.1016/j.semcdb.2023.06.007. Epub 2023 Jun 28.
9
CD36 and Its Role in Regulating the Tumor Microenvironment.CD36 及其在调控肿瘤微环境中的作用。
Curr Oncol. 2022 Oct 27;29(11):8133-8145. doi: 10.3390/curroncol29110642.
10
Controlled extracellular proteolysis of thrombospondins.调控性细胞外蛋白水解血栓反应蛋白。
Matrix Biol. 2023 May;119:82-100. doi: 10.1016/j.matbio.2023.03.011. Epub 2023 Mar 30.

引用本文的文献

1
THSD1 Is a Multifaceted Regulator in Health and Disease.THSD1是健康与疾病中的多面调节因子。
Biomedicines. 2025 May 24;13(6):1292. doi: 10.3390/biomedicines13061292.
2
Cell-Instructive Biomaterials with Native-Like Biochemical Complexity.具有类天然生化复杂性的细胞指导性生物材料。
Annu Rev Biomed Eng. 2025 May;27(1):185-209. doi: 10.1146/annurev-bioeng-120823-020209. Epub 2025 Jan 28.
3
Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers.针对甲状腺癌血管生成与免疫微环境之间相互作用的治疗方法。
Curr Opin Endocr Metab Res. 2024 Dec;37. doi: 10.1016/j.coemr.2024.100544. Epub 2024 Aug 14.
4
THBS2 promotes gastric cancer progression and stemness via the Notch signaling pathway.THBS2通过Notch信号通路促进胃癌进展和干性。
Am J Cancer Res. 2024 Jul 15;14(7):3433-3450. doi: 10.62347/UXWK4038. eCollection 2024.
5
Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer.整合批量RNA测序和单细胞RNA测序分析揭示了血小板反应蛋白在结肠癌中的功能和临床价值。
Comput Struct Biotechnol J. 2024 May 17;23:2251-2266. doi: 10.1016/j.csbj.2024.05.021. eCollection 2024 Dec.
6
Unveiling the Potential of Extracellular Vesicles as Biomarkers and Therapeutic Nanotools for Gastrointestinal Diseases.揭示细胞外囊泡作为胃肠道疾病生物标志物和治疗纳米工具的潜力。
Pharmaceutics. 2024 Apr 21;16(4):567. doi: 10.3390/pharmaceutics16040567.
7
Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy.CD47 靶向治疗在癌症免疫治疗中的机遇与挑战。
Oncol Res. 2023 Nov 15;32(1):49-60. doi: 10.32604/or.2023.042383. eCollection 2023.